Success Story: NIW Victory for A Biostatistician! Approved with Premium Processing and Our Strategic Support

Client’s Testimonial:

“NAILG’s attorney team has been communicative and professional. They always provide on-time feedback and further instructions. This makes the application process clear and straightforward. Highly recommended.”

On March 9^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Biostatistician I in the Field of Biostatistics (Approval Notice).

General Field: Biostatistics

Position at the Time of Case Filing: Biostatistician I

Country of Origin: Taiwan

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: March 9^th, 2025

Processing Time: 1 month, 20 days (Premium Processing Requested)

Case Summary:

We are pleased to share the successful approval of an I-140 NIW (National Interest Waiver) petition for a skilled professional in the field of biostatistics. This rapid adjudication reflects the exceptional value and national importance of the petitioner’s work, which centers on enhancing the design and analysis of clinical trials through advanced statistical methodologies and machine learning.

With an MS degree in biostatistics and a background in public health, the petitioner has contributed to critical research aimed at improving drug development for oncology, cardiovascular diseases, and infectious diseases. His proposed endeavor focuses on creating innovative tools that optimize clinical trial accuracy, accelerate therapeutic approvals, and ultimately improve public health outcomes in the U.S. and globally.

Currently employed as a biostatistician, the petitioner supports ongoing clinical studies by designing and implementing statistical analysis plans, particularly for phase I/II trials. His work ensures regulatory compliance and addresses pressing challenges in evaluating treatment-emergent safety, especially in complex conditions such as heart disease and cancer.

In support of his EB-2 NIW petition, we documented:

● 3 peer-reviewed journal articles,

● 5 conference abstracts, including 1 first-authored,

● A total of 38 citations, reflecting his influence in the research community,

● Multiple papers ranked among the top 10–20% most cited in clinical medicine for their publication years.

The significance of his research is further underscored by notable funding from prestigious institutions, including the National Institutes of Health, the National Heart, Lung, and Blood Institute, the National Cancer Institute, and the American Heart Association. This level of support highlights the national impact and trust placed in the petitioner’s methodologies.

To bolster his petition, 2 recommendation letters from field experts were submitted, including one from an independent source. These letters attest to the originality and practical application of his work across multiple high-need therapeutic areas.

“[Client] has and continues to contribute valuable research to understand the psychological strain placed on healthcare workers during public health crises. This speaks to his sustained leadership in biostatistics research and warrants the continuation of his work.”

We are honored to have supported this client’s NIW journey through NAILG. His continued contributions to clinical trial science promise to shape the next generation of life-saving therapies with greater precision and speed, further strengthening public health infrastructure in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.